Arcellx (ACLX)

• Market cap: $4.85B
• 1 day: 1.71%
• 5 days: 3.83%
• 1 month: 6.58%
• 3 months: 22.31%
• 6 months: 34.72%
• Year to date: 11.11%
• 1 year: 0.79%
• 5 years: 420.83%
• 10 years: 420.83%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163